Enfermedad por Mycobacterium kansasii

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 17, Issue 2, 1999, Pages 85-90

  Repáraz, Jesús ^a,b  

^a Universidad Pública de Navarra   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; OFLOXACIN; RIFAMPICIN; SULFAMETHOXAZOLE; TUBERCULOSTATIC AGENT;

ATYPICAL MYCOBACTERIUM; BACTERIAL COLONIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG DISEASE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REVIEW; SKIN INFECTION;

HUMANS; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM KANSASII;

EID: 0033033722     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Timpe A, Runyon EH. Relationship of atypical acid-fast bacilli to human disease: preliminery report. J Lab Clin Med 1954; 44: 202-209.
2. Böttger EC. Mycobacterium genavense: an emerging pathogen. Eur J Clin Microbiol Infect Dis 1991; 13: 932-936.
3. Moulsdale MT, Harper JM, Thatcher GN. Infection by Mycobacterium haemophilum, a metabolically fastidious acid-fast bacillus. Tubercle 1983; 64:29-36.
4. Griffith DE, Girard WM, Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria: an analysis of 154 patients. Am Rev Respir Dis 1993; 147: 1.271-1.278.
5. Horsburgh CR, Selik RM. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome. Am Rev Respir Dis 1989; 139: 4-7.
6. Wolinsky E. State of the Art: non-tuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979; 119: 107-159.
7. Woods GL, Washington JA. Mycobacteria other than Mycobacterium tuberculosis. Review of microbiologic and clinical aspects. Rev Infect Dis 1987; 9: 275-294.
8. Buhler VB, Pollak A. Human infection with atypical acid-fast organisms. Am J Clin Pathol 1953; 23: 363-374.
9. Picardeau M, Prod'Hom G, Raskine L, Le Pennee, Vincent V. Genotypic characterization of five subspecies of Mycobacterium kansasii. J Clin Microbiol 1997; 35: 25-32.
10. Wallace RJ Jr, Dunbar D, Brown BA, Onyi G, Dunlap R, Ahn CH et al. Rifampin-resistant Mycobacterium kansasii. Clin Infect Dis 1994; 18: 736-743.
11. Young LS, Berlin OGW, Inderlied CB. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria. Am J Med 1987; 82 (Supl 4A): 23-26.
12. Hopewell MP, Cyamon M, Starke J, O'Brien R. Evaluation of new antiinfective drugs for the treatment of disease caused by Mycobacterium kansasii and other mycobacterium. Clin Infect Dis 1992; 15 (Supl 1): 307-312.
13. Wolinsky E, Rynearson TK. Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respir Dis 1968; 97: 1.032-1.037.
14. Steadman JE. High-catalase strains of Mycobacterium kansasii isolated from water in Texas. J Clin Microbiol 1980; 11: 496-493.
15. Bailey RK, Wyles S, Dingley M, Hesse F, Kent GW. The isolation of high-catalase Mycobacterium kansasii from tap water. Am Rev Respir Dis 1970; 101: 430-431.
16. Pang SC. Mycobacterium kansasii infections in western Australia (1962-1937). Respir Med 1991; 85: 213-218.
17. Bittner MJ, Horowitz EA, Safranck TJ, Preheim LC. Emergence of Mycobacterium kansasii as the leading mycobacterial pathogen isolated over a 20-year period at a midwestern Veterans Affairs Hospital. Clin Infect Dis 1996; 22: 1.109-1.110.
18. Tsukamura M, Kita N, Shimoide H, Arakawa H, Kuze A. Studies on the epidemiology of nontuberculous mycobacteriosis in Japan. Am Rev Respir Dis 1988; 137: 1.280-1.284.
19. Yamamoto M. Pulmonary diseases due to Mycobacterium kansasii in Japan. Intern Med 1997; 36: 240-241.
20. Levine B, Chaisson RE. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus infection. Ann Intern Med 1991; 114: 861-868.
21. Urkijo JC, Montejo M, Aguirrebengoa K, Urra E, Aguirre C. Enfermedad por Mycobacterium kansasii en pacientes con infcccion por VIH. Enferm Infecc Microbiol Clin 1993; 11: 120-125.
22. Bamberger DM, Driks MR, Gupta MR, O'Connor MC, Jost PM, Neihart RE et al. Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Clin Infect Dis 1994; 18: 395-400.
23. Campo RE, Campo CE. Mycobacterium kansasii disease in patients infected with human immunodeficiency virus. Clin Infect Dis 1997; 24: 1.233-1.238.
24. Fishman JE, Schwartz DS, Sais GJ. Mycobacterium kansasii pulmonary infection in patients with AIDS: spectrum of chest radiographic findings. Radiology 1997; 204: 171-175.
25. Montessori V, Philips P, Montaner J, Haley L, Craib K, Bessuille E et al. Species distribution in human immunodeficiency virus-related mycobacterial infections: implications for selection of initial treatment. Clin Infect Dis 1996; 22: 989-992.
26. Carpenter JL, Parks JM. Mycobacterium kansasii infections in patients positive for human immunodeficiency virus. Clin Infect Dis 1991; 13: 789-796.
27. Witzig RS, Fazal BA, Mera RM, Mushatt DM, Dejace P, Greer DL et al. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus tipe 1. Clin Infect Dis 1995; 21: 77-85.
28. Valainis GT, Cardona ML, Greer DL. The spectrum of Mycobacterium kansasii disease associated with HIV- infected patients. J Acquir Immune Defic Syndr 1991; 4: 516-520.
29. Sherer R, Sable R, Sonnenberg M. Diseminated infection with Mycobacterium kansasii in the acquired immunodeficiency syndrome. Ann Intern Med 1986; 105: 710-712.
30. Hernández Flix S, Sauret J, Ausina V. Enfermedad pulmonar por microbacterias ambientales oportunistas. Revision de 35 casos. Med Clin (Barc) 1990; 95: 53-56.
31. Martin Casabona N, Gonzalez Fuente T, Fernández Pérez. Micobacteriosis: presentación de 38 casos. Med Clin (Bare) 1985; 84: 651-654.
32. Echevarría MP, Martin G, Pérez J, Urkijo JC. Enfermedad pulmonar por Mycobacterium kansasii. Presentación de 27 casos. Enferm Infecc Microbiol Clin 1994; 12: 280-284.
33. Lillo M, Orengo S, Cernoch P, Harris RL. Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience. Rev Infect Dis 1990; 12: 760-767.
34. Owens MW, Kinasewitz GT, Gonzalez E. Sandblaster's lung with mycobacterial infection. Am J Med Sci 1988; 295: 554-557.
35. Falkinham JO. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 1996; 9: 177-215.
36. Oermann CM, Starke JR, Seilheimer DK. Pulmonary disease caused by Mycobacterium kansasii in a patient with cystic fibrosis. Pediatr Infect Dis J 1997; 16: 257-259.
37. Jarret P, Ford G. Mycobacterium kansasii infection in a patient presenting with porfhyria cutanea tarda. Clin Exp Dermatol 1996; 21: 286-287.
38. Komeno T, Itoh T, Ohtani K, Kamoshita M, Hasegawa Y, Hiri M et al. Disseminated nontuberculous mycobacteriosis caused by Mycobacterium kansasii in a patient with myelodisplastic syndrome. Intern Med 1996; 35: 323-326.
39. Breathnach A, Levcll N, Munro C, Natarajan S, Pedler S. Cutaneous Mycobacterium kansasii infection: case report and review. Clin Infect Dis 1995; 20: 812-817.
40. Fraser DW, Buxton AE, Naji A. Disaseminated Mycobacterium kansasii infection presenting as cellulitis in a recipient of a renal homograft. Am Rev Respir Dis 1975; 112: 125-129.
41. Anzalone G, Cei M, Vizzaccaro A, Tramma B, Bisctti A. Mycobacterium kansasii pulmonary disease in idiopathic CD4 + T-lymphocytopenia. Eur Respir J 1996; 9: 1.754-1.756.
42. Wolinsky E, Rynearson TK. Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respir Dis 1968; 97: 1.032-1.037.
43. O'Brien RS, Geiter LS, Snider DE. The epidemiology of non-tuberculous myobacterial diseases in the United States: results of a national survey. Am Rev Respir Dis 1987; 135: 1.007-1.014.
44. Contreras MA, Cheung OT, Sanders DE, Goldstien RS. Pulmonary infections with nontuberculouos mycobacteria. Am Rev Respir Dis 1988; 137: 149-152.
45. Hornik DB, Dayton CS, Bedell GN, Fick RB Jr. Nontuberculouos mycobacterial lung disease. Substantiation of a less aggressive approach. Chest 1988; 93: 550-555.
46. Callahan EF, Licata AL, Madison JF. Cutaneous Mycobacterium kansasii infection associated with a papulonecrotic tuberculid reaction. J Am Acad Dermatol 1997; 36: 497-499.
47. Minkin BI, Mills CL, Bullock DW, Burke FD. Mycobacterium kansasii osteomyelitis of the scaphoid. J Hand Surg 1987; 12: 1.092-1.094.
48. Yamauchi T, Ferrieri P, Anthony BF. The actiology of acute cervical adenitis in children: serological and bacteriological studies. J Med Microbiol 1980; 13: 37-43.
49. Lee LW, Burgher LW, Price EB, Cassidy E. Granulomatous prostatitis. Association with isolation of Mycobacterium kansasii and Mycobacterium fortuitum. J Am Med Assoc 1977; 237: 2.408-2.409.
50. Flor A, Capdevila JA, Martin N, Gavalda J, Pahissa A. Nontuberculouos mycobacterial meningitis: report of two cases and review. Clin Infect Dis 1996; 23: 1.266-1.273.
51. Parenti DM, Symington JS, Keiser J, Simon GL. Mycobacterium kansasii bacteremia in patients infected with human immunodeficiency virus. Clin Infect Dis 1995; 21: 1.001-1.003.
52. Evans SA, Colville A, Evans AJ, Crisp AJ, Johnston IDA. Pumonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis. Thorax 1996; 51: 1.248-1.252.
53. Evans AJ, Crisp AJ, Hubbard RB, Colville A, Evans SA, Johnston IDA. Pulmonary Mycobacterium kansasii infection: comparison of radiological appearances with pulmonary tuberculosis. Thorax 1996; 51: 1.243-1.247.
54. Kurasawa T, Ikeda T, Inoue T, Nakatani K, Sato A, Ikeda N et al. Pulmonary infection with Mycobacterium kansasii presenting as solitary nodule shadow in the left anterior basal segment. Nippon Kyobu Shikkan Gakkai Zasshi 1997; 35: 215-219.
55. Chaisson RE, Schecter GF, Theur CP. Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy and survival. Am Rev Respir Dis 1987; 136: 570-574.
56. Wolinsky E. Mycobactcrial diseases other than tuberculosis. Clin Infect Dis 1992; 15: 1-10.
57. Lincoln EM, Gilbert LA. Disease in children due to mycobacteria other than M. tuberculosis. Am Rev Respir Dis 1972; 105: 683-714.
58. Owens DW, McBride ME. Sporotrichoid cutaneous infection with Mycobacterium kansasii. Arch Dermatol 1969; 100: 54-58.
59. Dore N, Collins JP, Mankiewickz E. A sporotrichoid-like Mycobacterium kansasii infection treated with minocycline-hidrochloride. Br J Dermatol 1979; 101: 75-79.
60. Lloveras J, Peterson PK, Simmons RL, Najarian JS. Mycobacterial infection in renal transplant recipients. Seven cases and a review of the literature. Arch Intern Med 1982; 142: 888-892.
61. Fitzek M, Ruhland D. Hodgkin's disease associated with generalised infection with Mycobacterium kansasii. Prax Pneumol 1972; 26: 543-547.
62. Nandwani R, Shanson DC, Fisher M, Nelson MR, Gazzard BG. Mycobacterium kansasii scalp abscesses in an AIDS patient. J Infect 1995; 31: 79-80.
63. Deabick JJ, Hoover DL, Rhot RE, Sauri MA, Apgar RG. Ulcerative perineal lesions due to Mycobacterium kansasii. J Am Acad Dermatol 1988; 18: 1.146-1.147.
64. Santa Cruz DJ, Strayer DS. The histologic spectrum of the cutaneous mycobacterioses. Hum Pathol 1982; 13: 485-495.
65. Maberry JD, Mullins JF, Stone OJ. Cutaneous infection due to Mycobacterium kansasii. JAMA 1965; 194: 1.135-1.137.
66. Lichtenstein IH, MacGregor RR. Mycobacterial infections in renal transplant recipients: report of five cases and review of the literature. Rev Infect Dis 1983; 5: 216-226.
67. Garcia Vivar ML, Gonzalez Etxavarri S, Galíndez E, Santamaría JM. Mycobacterium kansasii septic arthritis in a patient with acquired immunodeficiency syndrome. Arthritis Rheum 1996; 39: 881-882.
68. Friedman AW, Ike RW. Mycobacterium kansasii septic arthritis in a patient with acquired immunodeficiency syndrome. Arthritis Rheum 1993; 36: 1.631-1.632.
69. Kopple BS, Wormser GP, Tuchman AJ, Maayan S, Hewlett D Jr, Daras M. Central nervous system involvement in patients with acquired immunodeficiency syndrome. Acta Neurol Scand 1985; 71: 337-353.
70. Nuesch R, Battegay M, Zimmerli W, Thumshirn M, Gilli L, Itin PH. Oral manifestations of disseminated Mycobacterium kansasii infection in a patient with AIDS. Dermatology 1996; 192: 183-184.
71. Glickstein SL, Nashel DJ. Mycobacterium kansasii septic arthritis complicating rheumatic disease: case report and review of the literature. Semin Arthritis Rheum 1937; 16: 231-235.
72. American Thoracic Society. Diagnosis and treatment of disase caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997; 156 (Supl): 1-25.
73. Jenkins DE, Bahar D, Chofuas Y. Pulmonary disease due to atypical mycobacteria: current concepts. Transactions 19th Conference on Chemotherapy of Tuberculosis 1960; 224-231.
74. Pezzia W, Raleigh JW, Bailey MC, Toth EA, Silverblatt J. Treatment of pulmonary disease due to Mycobacterium kansasii: recent experience with rifampin. Rev Infect Dis 1981; 3: 1.035-1.039.
75. Ahn CH, Lowell JR, Ahn SA, Ahn S, Hurst GA. Chemotherapy for pulmonary disease due to Mycobacterium kansasii: efficacies of some individual drugs. Rev Infect Dis 1981; 3: 1.028-1.034.
76. Alin CH, Lowell JR, Ahn SA, Ahn S, Hurst GA. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii. Am Rev Respir Dis 1983; 128: 1.048-1.050.
77. Alangaden GJ, Lerner SA. The clinical use of fluorquinolones for the treatment of mycobacterial diseases. Clin Infect Dis 1997; 25: 1.213-1.221.
78. Jenkins PA, Banks J, Campbell IA, Smith AP. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of nine months of treatment with rifampin and ethambutol. Thorax 1994; 49: 442-445.
79. Ahn CH, Wallace RJ Jr, Steele LC, Murphy DT. Sulfonamide-containing regimens for disease caused by rifampin resistant Mycobacterium kansasii. Am Rev Respir Dis 1987; 135: 10-16.